At the molecular level, immunoblotting revealed that CPX treatment of GBM cells significantly reduced the expression of two pro-metastatic proteins, N-Cadherin and Snail, and of the pro-invasive protein, MMP9 (Fig. 2E). Here, CDH2 is linked to glioblastoma.